Projects and Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Post Doctoral Fellow, University Of Kentucky
1988
Residency, Baylor University
1986
Internship, Baylor University
1982
Doctor of Medicine, Yeshiva University
1981
Bachelor of Science, Stanford University
1977
Fingerprint
Dive into the research topics where Michael Sekela is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
CHIPS: CHIlled Platelet Study
Sekela, M. (PI) & Rockich, A. (CoI)
9/1/23 → 1/31/26
Project: Research project
-
CorMatrix Cor TRICUSPID ECM Valve Replacement Safety and Early Feasibility Study
Sekela, M. (PI)
CorMatrix Cardiovascular Incorporated
5/7/20 → 1/11/27
Project: Research project
-
SBIR Development of a Minimally Invasive Single Cannulation, Compact Single Port Pulsatile Ventricular Assist Device (sppVAD) for Total LV Support
Wang, D. (PI), Ballard Croft, C. (CoI), Sekela, M. (CoI) & Zwischenberger, J. (CoI)
10/1/21 → 6/30/23
Project: Research project
-
A Phase III, Multicenter, Open-Label, Extension Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow® Device plus Standard of Care in the Treatment
Nandavaram, S. (PI), Baz, M. (Former PI) & Sekela, M. (Former PI)
6/30/20 → 3/20/24
Project: Research project
-
On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study
Sekela, M. (PI)
9/20/19 → 7/15/21
Project: Research project
-
Amustaline/glutathione pathogen-reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 ReCePI trial
for the ReCePI Study Group, 2025, (Accepted/In press) In: Transfusion.Research output: Contribution to journal › Article › peer-review
Open Access -
Antibiotic treatment duration for isolated methicillin-susceptible Staphylococcus aureus native tricuspid valve endocarditis: a standardized multidisciplinary approach
El-Dalati, S., Collis, B., Hall, E., Alnabelsi, T., Cao, C., Johnson, M., Gurley, J., Strnad, L., Reda, H., Sekela, M., Mansoor, A. E. R., Olafsson, D., Harris, W. & Stoner, B. J., Oct 1 2025, In: JAC-Antimicrobial Resistance. 7, 5, dlaf171.Research output: Contribution to journal › Article › peer-review
Open Access -
Management of Cardiovascular Implantable Electronic Device Infection Utilizing a Multidisciplinary Team: A Retrospective Cohort Study
Hall, E., Collis, B., Alnabelsi, T., Cao, C., Johnson, M., Gurley, J., Strnad, L., Reda, H., London, T., Ogburn, E., Sekela, M., Stoner, B. J. & El-Dalati, S., Apr 1 2025, In: Open Forum Infectious Diseases. 12, 4, ofaf148.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Midterm survival, clinical, and hemodynamic outcomes of a novel mechanical mitral valve prosthesis
PROACT Mitral Investigators, Oct 2025, In: Journal of Thoracic and Cardiovascular Surgery. 170, 4, p. 1060-1068.e3Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Outcomes associated with absent blood product utilization in Jehovah’s witness patients compared to the standard of care in cardiac surgery: A ten-year experience
Fields, N., Ather, A., Davenport, D., Ahmed, S. & Sekela, M., May 2025, In: Perfusion (United Kingdom). 40, 4, p. 869-876 8 p.Research output: Contribution to journal › Article › peer-review
Open Access